The global cell therapy technologies market is witnessing strong momentum as regenerative medicine continues to redefine the future of healthcare. Valued at approximately US$ 14.9 Bn in 2022, the market is projected to expand at a CAGR of 10.5% from 2023 to 2031, reaching nearly US$ 36.0 Bn by 2031. This rapid growth reflects rising clinical success of cell-based therapies and increasing global...